CYC
Cyclopharm Limited
🇦🇺 ASX
📈 HIGH PRICE GROWTH
🩺 HEALTH CARE
👑 Overview
📈 Performance
💰 Dividends
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
+ 14.61%
Annual Growth
5 years average annual growth
💰
0.42%
Annual dividend yield
Based on the most recent dividend
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
10
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Cyclopharm Ltd. is a radiopharmaceutical company, which engages in diagnostic imaging in lung health. The firm's principal activity is engaged in the manufacture and sale of medical equipment and radiopharmaceuticals, including associated research and development and distribution of third-party products to the diagnostic imaging sector. Its segments include Technegas and Molecular Imaging. The Technegas segment is a supplier of diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism and a distributor of products to the diagnostic imaging sector. The Molecular Imaging segment produces radiopharmaceuticals to be used by physicians in the detection of cancer, neurological disorders and cardiac disease. The firm uses Technegas technology, which is a structured ultra-fine dispersion of radioactive labelled carbon, produced by using driedTechnetium-99m in a carbon crucible. The firm distributes its products in approximately 65 countries.
📈 Performance
Price History
+346.19%
1M
1Y
10Y
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💰 Dividends
Payouts
💰 Annual Dividend Yield*
0.42%
💰 Annual Dividend Earnings Per $1,000 invested**
$4.17
💰 Most Recent Dividend Franked Percentage Estimate
0.00%
💰 Average Dividend Franked Percentage Estimate
82.00 %
💰 Dividend reinvestment
* Based on the most recent dividend
** Calculated by multiplying the most recent dividend yield by $1,000
Estimate your dividend
If you held
$
of CYC, your last dividend payment(s) would have been:
$ 20.83
on Mon Sep 11 2023
$ 33.33
on Tue Apr 04 2023
*Disclaimer: The information provided in this calculator is only a model to show you how long you need to invest for to achieve your goal, based on several factors, including past performance which is not an indicator of future performance. It is not a prediction and relies on assumptions, such as interest rates, that may vary and change the actual outcome. The results shown are only estimates and are not intended to be relied on when making a financial decision. Consider whether to get advice from a licensed financial adviser before making any financial decision.
Dividend History
1Y
5Y
10Y
Graph
Table
Year
Yearly Dividend Earnings Per Share
Franking Estimate
2025
$0.00
0.00%
2024
$0.00
0.00%
2023
$0.01
0.00%
2022
$0.01
0.00%
2021
$0.01
0.00%
2020
$0.01
0.00%
2019
$0.01
0.00%
2018
$0.01
0.00%
2017
$0.01
0.00%
2016
$0.01
0.00%
💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$1.99
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in CYC
10
📊 Total Capital Earnings
$60.24
🔃 Average investment frequency
23 weeks
💵 Average investment amount
$2,236
⏰ Last time a customer invested in CYC
6 days
CYC investor breakdown
💵 Income of investors
More than 200k
150k - 200k
10%
100k - 150k
30%
50k - 100k
30%
Less than 50k
30%
👶 Age of investors
18 - 25
20%
26 - 34
20%
35 - 90
60%
🙋 Legal gender of investors
Female
60%
Male
40%
Pearlers who invest in CYC also invest in...
VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
3.16%
📊 Share price
$102.62 AUD
🇦🇺 AUSTRALIA
💸 FINANCIALS
🧱 MATERIALS
⛳️ DIVERSIFIED
IVV.AX was created on 2007-10-10 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.
🙌 Performance (5Yr p.a)
17.85%
📊 Share price
$63.15 AUD
📈 HIGH PRICE GROWTH
🇺🇸 UNITED STATES
Telix Pharmaceuticals Ltd. engages in the development and commercialization of several clinical-stage oncology assets. The company is headquartered in Melbourne, Victoria. The company went IPO on 2017-11-15. The company develops a portfolio of clinical and commercial stage products that addresses significant unmet medical needs in oncology and rare diseases. The company operates a pipeline of theranostic radiopharmaceutical product candidates with a focus in urologic oncology (prostate and kidney), neuro-oncology (glioma), musculoskeletal oncology (sarcoma) and bone marrow conditioning. The company operates under four business units: Therapeutics, Precision Medicine (Diagnostics), Lightpoint (Medtech), and Telix Manufacturing Solutions (TMS). Its lead imaging product is gallium-68 (68Ga) gozetotide injection (also known as 68Ga PSMA-11 and marketed under the brand name Illuccix). Its other pipelines include TLX591, TLX592, TLX250, TLX250-CDx, TLX101, TLX101-CDx, TLX300, TLX300-CDx, TLX66, and TLX66-CDx.
🙌 Performance (5Yr p.a)
378.68%
📊 Share price
$30.10 AUD
🧬 BIOTECHNOLOGY
NDQ.AX was created on 2015-05-26 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The fund aims to track the performance of the NASDAQ-100 Index (before fees and expenses). The NASDAQ-100 comprises 100 of the largest non-financial companies listed on the NASDAQ market, and includes many companies that are at the forefront of the new economy.
🙌 Performance (5Yr p.a)
22.49%
📊 Share price
$50.63 AUD
📈 HIGH PRICE GROWTH
🇺🇸 UNITED STATES
🤖 TECHNOLOGY
VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
12.69%
📊 Share price
$141.25 AUD
🤖 TECHNOLOGY
🌏 GLOBAL
⛳️ DIVERSIFIED
📈 HIGH PRICE GROWTH
Want more shares? Try these...
Aucyber Ltd is a AU-based company operating in IT Services industry. The company is headquartered in Canberra, Australian Capital Territory. The company went IPO on 2020-12-14. AUCyber Limited, formerly Sovereign Cloud Holdings Limited, is an Australia-based technology company. The firm specializes in delivering highly secure cloud infrastructure alongside managed cybersecurity and consulting services for prominent enterprise and government customers. The firm encompasses brands: AUCyber and AUCloud, Australian sovereign providers of comprehensive cybersecurity, secure private cloud and managed technology services. With national operations, the Company leverages the sovereign cloud infrastructure and employs Australian security-cleared engineers, security analysts, IT professionals, and holds the highest security accreditations. Its solutions are backed by key certifications, including the Digital Transformation Agency’s Hosting Certification Framework and compliance with the Australian Signals Directorate’s Information Security Manual. These certifications provide customers with confidence in the security and quality of its services.
📊 Share price
$0.12 AUD
🤖 TECHNOLOGY